论文部分内容阅读
心房颤动(房颤)是临床上最常见的一种心律失常,房颤患病率随年龄而明显增加。其病因过去常见于风湿性心脏瓣膜病,近年来随着老龄化的加剧,非瓣膜病导致的房颤在临床上还将继续增加。卒中是非瓣膜病房颤患者致死和致残的主要危险因素,房颤患者卒中风险是非房颤患者的5倍~[1]。因此,老年人房颤的抗凝治疗是临床关注及研究的重点。1资料与方法1.1临床资料选择2011年2月至2013年2月在我院治疗
Atrial fibrillation (AF) is the most common clinical arrhythmia, the prevalence of atrial fibrillation significantly increased with age. The etiology of the past common in rheumatic heart valve disease, in recent years as the aging intensified, non-valvular atrial fibrillation caused by the clinical will continue to increase. Stroke is a major risk factor for death and disability in patients with nonvalvular atrial fibrillation, and the risk of stroke in patients with atrial fibrillation is five-fold to non-atrial fibrillation [1]. Therefore, the anticoagulant therapy of atrial fibrillation in the elderly is the focus of clinical attention and research. 1 Materials and Methods 1.1 Clinical data options February 2011 to February 2013 in our hospital for treatment